Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Neoplasm Metastasis 3Uterine Cervical Neoplasms 2Neoplasms 2Camurati-Engelmann Syndrome 2Recurrence 1Rectal Neoplasms 1Prostatic Neoplasms 1Nasopharyngeal Carcinoma 1Microsatellite Instability 1Metastatic Solid Tumors 1Mesothelioma, Malignant 1Mesothelioma 1Lung Neoplasms 1Head and Neck Neoplasms 1Gallbladder Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Cholangiocarcinoma 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Biliary Tract Neoplasms 1Anatomic Stage II Breast Cancer AJCC v8 1

Interventions

tremelimumab 1durvalumab 1bintrafusp alfa protein, human 1Immunoglobulin G 1Disulfides 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Anatomic Stage II Breast Cancer AJCC v8 × bintrafusp alfa protein, human × Clear all
NCT03620201 2024-10-22

M7824 in Treating Patients With Stage II-III HER2 Positive Breast Cancer

M.D. Anderson Cancer Center

Phase 1 Completed
20 enrolled
Breast

Anatomic Stage II Breast Cancer AJCC v8

Data powered by HemOnc (CC BY 4.0) Colophon âš¡